All-arthroscopic AMIC® (AT-AMIC®) technique with autologous bone graft for talar osteochondral defects: clinical and radiological results
Authors:
- Federico Giuseppe UsuelliFUFederico Giuseppe Usuelli
- Riccardo D’aMbrosiRDRiccardo D’aMbrosi
- Laura de GirolamoLGLaura de Girolamo
Open Access
- 12 September 2016
- journal article
- research article
- Published by Wiley in Knee Surgery, Sports Traumatology, Arthroscopy
- Vol. 26 (3) , 875-881
Abstract
Autologous Matrix-Induced Chondrogenesis (AMIC®) is known to provide satisfactory clinical results for the treatment of knee, hip, and ankle cartilage lesions. The purpose of this study was to evaluate clinical and radiological outcomes of patients treated with a new all-arthroscopic AMIC® (AT-AMIC®) technique with autologous bone graft for talar osteochondral defects at a follow-up of 24 months. Twenty patients underwent the AT-AMIC® procedure and autologous bone graft for type III and IV talar osteochondral lesions. Patients were evaluated pre-operatively and at 6, 12, and 24 months post-operatively using the American Orthopedic Foot and Ankle Society (AOFAS) score, the visual analog scale, and the SF-12 (Short Form-12). Radiological assessment included computed tomography (CT), magnetic resonance imaging (MRI), and magnetic resonance observation of cartilage repair tissue (MOCART). All scores significantly improved (p < 0.05) with respect to pre-operative values after 6 months. Further improvements were detected at 24 months (AOFAS, from 57.1 ± 14.9 before surgery to 86.6 ± 10.9 after 24 months; VAS, from 8.1 ± 1.4 to 2.5 ± 2.2; SF-12, from 29.9 ± 4.1 to 48.5 ± 6.9 and from 43.8 ± 2.9 to 53.1 ± 3.9, respectively, for Physical and Mental component score). Lesion area significantly reduced from 111.1 ± 43.2 mm2 pre-operatively to 76.9 ± 38.1 mm2 (p < 0.05) at final follow-up as assessed by CT, and from 154.1 ± 93.6 to 94.3 ± 61.3 mm2 (p < 0.05) as assessed by MRI. The mean MOCART score was 42.8 ± 23.5 points and 50.9 ± 24.9 points, respectively, at 12 and 24 months after surgery (p < 0.05). AT-AMIC® with autologous bone grafting has proven to be a safe and effective minimal invasive technique, able to rapidly and significantly improve pain, function, and radiological healing of osteochondral talar lesions, with progressive further improvements up to 24 months. Orthopedic surgeons specialized in foot and ankle surgery should adopt the AT-AMIC® technique for the treatment of osteochondral talar lesions, which proved to be effective and minimally invasive, avoiding malleolar osteotomy with a low risk of complications. IV.Keywords
This publication has 28 references indexed in Scilit:
- Delayed gadolinium-enhanced MRI of cartilage of the ankle joint: Results after autologous matrix-induced chondrogenesis (AMIC)-aided reconstruction of osteochondral lesions of the talusClinical Radiology, 2013
- Arthroscopic autologous chondrocyte implantation in the ankle jointKnee Surgery, Sports Traumatology, Arthroscopy, 2013
- Reconstruction of Osteochondral Lesions of the Talus With Autologous Spongiosa Grafts and Autologous Matrix-Induced ChondrogenesisThe American Journal of Sports Medicine, 2013
- A Novel Imaging Method for Osteochondral Lesions of the Talus—Comparison of SPECT-CT With MRIThe American Journal of Sports Medicine, 2011
- Arthroscopic Treatment of Osteochondral Lesions of the Ankle With Matrix-Associated Chondrocyte ImplantationThe American Journal of Sports Medicine, 2010
- Osteochondral defects in the ankle: why painful?Knee Surgery, Sports Traumatology, Arthroscopy, 2010
- Osteochondral Lesion of the TalusThe American Journal of Sports Medicine, 2009
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- Clinical Rating Systems for the Ankle-Hindfoot, Midfoot, Hallux, and Lesser ToesFoot & Ankle International, 1994
- A critical review of visual analogue scales in the measurement of clinical phenomenaResearch in Nursing & Health, 1990